Search company, investor...

Founded Year

2003

Stage

Acquired | Acquired

About Theken Disc

Theken Disc designs develops, and manufactures spinal arthroplasty products, such as the eDisc, a microelectronic artificial spinal disc replacement. It was founded in 2003 and is based in Akron, Ohio. In January 2009, Theken Disc was acquired by Integra LifeSciences. The terms of the transaction were not disclosed.

Headquarters Location

Akron, Ohio, 44301,

United States

Loading...

Loading...

Theken Disc Patents

Theken Disc has filed 56 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/13/2015

7/18/2017

Bone fractures, Orthopedic surgical procedures, Pelvis, Neurosurgery, Gobots

Grant

Application Date

7/13/2015

Grant Date

7/18/2017

Title

Related Topics

Bone fractures, Orthopedic surgical procedures, Pelvis, Neurosurgery, Gobots

Status

Grant

Latest Theken Disc News

Theken Companies Acquires VisionAir Solutions

Aug 22, 2023

News provided by Share this article Theken Companies announces its acquisition of VisionAir Solutions from Cleveland Clinic. AKRON, Ohio, Aug. 22, 2023 /PRNewswire/ -- Theken Companies, an Akron, Ohio-based family of medical device companies, today announced its acquisition of VisionAir Solutions from Cleveland Clinic. VisionAir Solutions creates patient-specific airway stents with its 3D-design platform. VisionAir 3D Patient-Specific Stents provide improved stent life, increased time between interventions, and reduced complications for an improved patient quality of life. Theken Companies Acquires VisionAir Solutions - The Physicians' Preferred Airway Stent VisionAir 3D Stents are personalized by pulmonologists using innovative cloud software (VisionAir 3D Stent Architect). With this unique software a physician simply uploads a patient's scans and receives a personalized silicone stent within days that fits the patient's specific anatomy near to perfect. This allows physicians to tailor a 3D Stent to each patient's unique anatomy to reduce complications caused by poorly-fitting stock silicone stents. Instead of an average stock stent life of 60 days, these patient-specific stents have an average life of years, although the VisionAir stent is clinically approved by the FDA for one year. To see how simple the process is, view the video here: https://www.visionairsolutions.com/videos#simple-as-1-2-3 VisionAir stents have broad indications for the treatment of symptomatic central airway obstruction (CAO) in mature individuals that are 22 years of age or older. 3D Stents may be implanted in any location in the airway that a physician can reach with a rigid bronchoscope for implantation. This means that the 3D Stent is unique in that it can be designed to fit carinas distal to the main carina, while current traditional silicone Y-stents have stock diameters, angles, and lengths specifically designed for only the main carina. Randy Theken, Founder of Theken Companies, said of the acquisition, "I was truly overwhelmed by the technology created by the VisionAir team at Cleveland Clinic. The VisionAir 3D Patient-Specific Stents provide significantly improved stent life and an improved patient quality of life. This is exciting not only for the pulmonary field, but for the potential to apply this technology to other medical devices." Thomas Gildea, MD, FCCP, FACP, of Cleveland Clinic and Inventor and Head of the Clinical Advisory Team at VisionAir Solutions, stated, "We are excited to collaborate with Randy Theken and the new VisionAir team. They continue to share our vision of bringing innovative technology to as many patients as possible." Cleveland Clinic has an equity interest in VisionAir and is entitled to royalty payments and other commercialization revenues from the company for technology developed at Cleveland Clinic. VisionAir is the developer and manufacturer of the stents. Dr. Gildea and others at Cleveland Clinic are inventors and are entitled to royalty payments and other commercialization revenues from the company in accordance with Cleveland Clinic policy. About Theken Companies Theken Companies, LLC is a family of medical device companies headquartered in Akron, Ohio. Theken has successfully founded over ten medical implant device companies since 1992. Three of these companies (Theken Spine LLC, Theken Disc LLC, Therics, LLC) were acquired in 2009 by Integra LifeSciences. Theken then founded five new medical device companies focused on joint replacements, medical ceramics, medical microelectronics, medical antimicrobial coatings, and medical 3D printing and manufacturing. Theken now adds VisionAir Solutions to its portfolio. Learn more about Theken's history at: www.theken.us About VisionAir Solutions VisionAir 3D Stents are personalized silicone stents tailored to a patient's unique airway anatomy and are manufactured using our proprietary cloud-based software and 3D-printed medical-grade silicone technology. It's known as the "physicians' preferred airway stent" because it has a patient-perfect fit, multi-year stent life, with reduced complications. Learn more at: www.visionairsolutions.com SOURCE VisionAir Solutions

Theken Disc Frequently Asked Questions (FAQ)

  • When was Theken Disc founded?

    Theken Disc was founded in 2003.

  • Where is Theken Disc's headquarters?

    Theken Disc's headquarters is located at Akron.

  • What is Theken Disc's latest funding round?

    Theken Disc's latest funding round is Acquired.

  • Who are the investors of Theken Disc?

    Investors of Theken Disc include Integra LifeSciences and Bounce Innovation Hub.

  • Who are Theken Disc's competitors?

    Competitors of Theken Disc include Vertos Medical, AxioMed, Noraker, Spine Wave, LDR Holding and 7 more.

Loading...

Compare Theken Disc to Competitors

S
SpinalMotion

SpinalMotion is a medical device company focused on designing, developing and marketing advanced artificial discs for use in the spine. Its Kineflex Technology is intended to preserve motion in the spine for patients suffering from degenerative disc disease (DDD) in the cervical and lumbar spine.

D
Disc Dynamics

Disc Dynamics has developed the DASCORTM Disc Arthroplasty System, an innovative, minimally invasive nucleus replacement treatment for patients suffering from chronic low back pain caused by Degenerative Disc Disease (DDD).

Spine Wave Logo
Spine Wave

Spine Wave is a medical device company. It develops a procedure for treating back pain and other spinal conditions by restoring the function of the spinal disc. It uses an injectable protein-based formulation for the repair of spinal discs damaged either by injury or aging. It was founded in 2001 and is based in Shelton, Connecticut.

S
Spinal Restoration

Spinal Restoration restores patients' lives by delivering new therapies that address unmet needs in spine health management. These therapies are minimally invasive, early interventions with clinically proven results. The company is working with a diverse, highly regarded group of clinical and scientific advisors to develop and gain regulatory approval of the Biostat System, a proprietary resorbable biologic and delivery system for the treatment of chronic disc pain, based on solid scientific and clinical evidence.

O
Orthonics

Orthonicsis a company created through Georgia Tech's Venturlab program. Orthonics is developing biomaterials for orthopaedic tissue engineering applications. The company's core technology relates to biomaterials that permit in-growth and adhesion of bone and cartilage tissues. Initial applications will be spinal disc replacement and as aspinal disc annulus patch.

A
AxioMed

AxioMed aims to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. The company was founded in 2001 and is based in Malden, Massachusetts.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.